These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31295336)

  • 21. Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: a retrospective, nonrandomized autopsy study.
    Chamilos G; Luna M; Lewis RE; Chemaly R; Raad II; Kontoyiannis DP
    Clin Ther; 2007 Sep; 29(9):1980-6. PubMed ID: 18035197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model.
    Olson JA; Adler-Moore JP; Schwartz J; Jensen GM; Proffitt RT
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2122-31. PubMed ID: 16723574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary adenosine excretion in patients receiving amphotericin B.
    Carlson MA; Ferraz AA; Condon RE
    Surgery; 1997 Feb; 121(2):190-3. PubMed ID: 9037231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amphotericin B nephrotoxicity in children.
    Goldman RD; Koren G
    J Pediatr Hematol Oncol; 2004 Jul; 26(7):421-6. PubMed ID: 15218415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amphotericin B and its new formulations: pharmacologic characteristics, clinical efficacy, and tolerability.
    Tiphine M; Letscher-Bru V; Herbrecht R
    Transpl Infect Dis; 1999 Dec; 1(4):273-83. PubMed ID: 11428998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amphotericin B deoxycholate (d-AMB) use in cases with febrile neutropenia and fungal infections: lower toxicity with suitable premedication.
    Oto OA; Paydas S; Disel U; Yavuz S; Seydaoglu G
    Mycoses; 2007 Mar; 50(2):135-9. PubMed ID: 17305778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Burden of acute kidney injury in HIV patients under deoxycholate amphotericin B therapy for cryptococcal meningitis and cost-minimization analysis of amphotericin B lipid complex.
    Tuon FF; Florencio KL; Rocha JL
    Med Mycol; 2019 Apr; 57(3):265-269. PubMed ID: 29762761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse effects of amphotericin B in children; a retrospective comparison of conventional and liposomal formulations.
    Andrew EC; Curtis N; Coghlan B; Cranswick N; Gwee A
    Br J Clin Pharmacol; 2018 May; 84(5):1006-1012. PubMed ID: 29352486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Restoration of Vitamin D Levels Slows the Progression of Renal Ischemic Injury in Rats Previously Deficient in Vitamin D.
    Dos Santos MS; Canale D; Bernardo DRD; Shimizu MHM; Seguro AC; Volpini RA; de Bragança AC
    Front Med (Lausanne); 2021; 8():625647. PubMed ID: 33869246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin D Deficiency Aggravates the Renal Features of Moderate Chronic Kidney Disease in 5/6 Nephrectomized Rats.
    de Bragança AC; Canale D; Gonçalves JG; Shimizu MHM; Seguro AC; Volpini RA
    Front Med (Lausanne); 2018; 5():282. PubMed ID: 30370270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amphotericin B nephrotoxicity: the adverse consequences of altered membrane properties.
    Sawaya BP; Briggs JP; Schnermann J
    J Am Soc Nephrol; 1995 Aug; 6(2):154-64. PubMed ID: 7579079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amphotericin B-induced nephrotoxicity: a review.
    Fanos V; Cataldi L
    J Chemother; 2000 Dec; 12(6):463-70. PubMed ID: 11154026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incorporation of amphotericin B (AMB) into liposomes alters AMB-induced acute nephrotoxicity in rabbits.
    Joly V; Dromer F; Barge J; Yeni P; Seta N; Molas G; Carbon C
    J Pharmacol Exp Ther; 1989 Oct; 251(1):311-6. PubMed ID: 2795463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-induced nephrotoxicity caused by amphotericin B lipid complex and liposomal amphotericin B: a review and meta-analysis.
    Safdar A; Ma J; Saliba F; Dupont B; Wingard JR; Hachem RY; Mattiuzzi GN; Chandrasekar PH; Kontoyiannis DP; Rolston KV; Walsh TJ; Champlin RE; Raad II
    Medicine (Baltimore); 2010 Jul; 89(4):236-244. PubMed ID: 20616663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo distribution and therapeutic efficacy of a novel amphotericin B poly-aggregated formulation.
    Espada R; Valdespina S; Dea MA; Molero G; Ballesteros MP; Bolás F; Torrado JJ
    J Antimicrob Chemother; 2008 May; 61(5):1125-31. PubMed ID: 18285313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute and chronic effects of flucytosine on amphotericin B nephrotoxicity in rats.
    Heidemann HT; Brune KH; Sabra R; Branch RA
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2670-5. PubMed ID: 1482135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of effective renal plasma flow, enzymuria, and cytokine release in healthy volunteers receiving a single dose of amphotericin B desoxycholate.
    Pai MP; Norenberg JP; Telepak RA; Sidney DS; Yang S
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3784-8. PubMed ID: 16127053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid formulations of amphotericin B preserve and stabilize renal function in HSCT recipients.
    Miller CB; Waller EK; Klingemann HG; Dignani MC; Anaissie EJ; Cagnoni PJ; McSweeney P; Fleck PR; Fruchtman SM; McGuirk J; Chao NJ
    Bone Marrow Transplant; 2004 Mar; 33(5):543-8. PubMed ID: 14730342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nephrotoxicity and other adverse events among inpatients receiving liposomal amphotericin B or amphotericin B lipid complex.
    Wade RL; Chaudhari P; Natoli JL; Taylor RJ; Nathanson BH; Horn DL
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):361-7. PubMed ID: 23774005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conventional Amphotericin B Associated Nephrotoxicity in Patients With Hematologic Malignancies.
    Gursoy V; Ozkalemkas F; Ozkocaman V; Serenli Yegen Z; Ethem Pinar I; Ener B; Akalın H; Kazak E; Ali R; Ersoy A
    Cureus; 2021 Jul; 13(7):e16445. PubMed ID: 34422476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.